M A Moskowitz, S R Coughlin. Show Affiliations »
Abstract
Entities: Chemical
Mesh： See more » AnimalsBrain/metabolismCerebrovascular Circulation/drug effectsCerebrovascular Disorders/metabolismDuctus Arteriosus, Patent/drug therapyEpoprostenol/adverse effectsEpoprostenol/therapeutic useHumansIschemic Attack, Transient/etiologyMigraine Disorders/drug therapyMigraine Disorders/etiologyProstaglandin Antagonists/therapeutic useProstaglandins/metabolismProstaglandins/physiologyProstaglandins/therapeutic useVascular Diseases/drug therapy
Substances： See more » Prostaglandin AntagonistsProstaglandinsEpoprostenol
Year: 1981 PMID： 7029794 DOI： 10.1161/01.str.12.6.882
Source DB: PubMed Journal: Stroke ISSN： 0039-2499 Impact factor: 7.914